Marc To Markets

Cancer: Treatment Today, Cutting Edge Innovation, and The Investment Opportunity

February 13, 2020 Marc Penziner, Ellen Neylon, Adam Waldman, Patrick Saunders Season 5 Episode 2
Marc To Markets
Cancer: Treatment Today, Cutting Edge Innovation, and The Investment Opportunity
Show Notes

On this episode I do a deep dive into cancer today.   Ellen Neylon, from the Center for Lymphoid Malignancies, talks about what to do should you or someone you know be diagnosed with the disease (5:09).  I’m then joined by Adam Waldman, an executive at TG Therapeutics, to discuss the most exciting advances in cancer treatment, and why he and others believe we are at inflection point in the fight (26:29).  Lastly, I’m joined by Patrick Saunders, a Healthcare Portfolio Manager, to discuss how to approach investment in the oncology, biotech, and healthcare sectors (41:00).

With any questions or comments, I can be reached at marc.penziner@bernstein.com or 212-969-6655.

The information presented and opinions expressed are solely the views of the podcast host commentator and their guest speaker(s).  AllianceBernstein L.P. or its affiliates makes no representations or warranties concerning the accuracy of any data. There is no guarantee that any projection, forecast or opinion in this material will be realized. Past performance does not guarantee future results. The views expressed here may change at any time after the date of this podcast. This podcast is for informational purposes only and does not constitute investment advice. AllianceBernstein L.P. does not provide tax, legal or accounting advice. It does not take an investor’s personal investment objectives or financial situation into account; investors should discuss their individual circumstances with appropriate professionals before making any decisions. This information should not be construed as sales or marketing material or an offer or solicitation for the purchase or sale of any financial instrument, product or service sponsored by AllianceBernstein or its affiliates.